Your browser doesn't support javascript.
loading
Conflicts of Interest Among Infectious Diseases Clinical Practice Guideline Authors and the Pharmaceutical Industry.
Ahiskali, Aileen S; Drekonja, Dimitri M; Alpern, Jonathan D.
Affiliation
  • Ahiskali AS; Department of Pharmacy, Hennepin Healthcare, Minneapolis, Minnesota.
  • Drekonja DM; Infectious Diseases Section, Minneapolis Veterans Affairs Healthcare System, Minneapolis, Minnesota.
  • Alpern JD; Department of Medicine, University of Minnesota, Minneapolis.
JAMA Netw Open ; 6(4): e238592, 2023 04 03.
Article in En | MEDLINE | ID: mdl-37067802
This cross-sectional study assesses the prevalence of conflicts of interest (COI) associated with guideline-recommended drugs among Infectious Diseases Society of America clinical practice guideline authors and compliance with the Council on Medical Specialty Societies and Institute of Medicine guidelines.
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Conflict of Interest / Medicine Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Conflict of Interest / Medicine Type of study: Guideline / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: JAMA Netw Open Year: 2023 Document type: Article Country of publication: United States